December 2025 in “International Journal of Dermatology” Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.
November 2025 in “Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin” Sporadic trichoblastic neoplasms generally don't recur or spread, with one case showing a specific genetic fusion.
November 2025 in “Journal of the European Academy of Dermatology and Venereology” Different types of hidradenitis suppurativa need specific treatments based on unique skin cell issues.
October 2025 in “International Journal of Dermatology” GLP-1 receptor agonists may cause hair loss, but regrowth is rare.
October 2025 in “Environment International” Exposure to certain chemicals before birth and during childhood may affect puberty timing.
October 2025 in “The American Journal of Gastroenterology” Early diagnosis and treatment of hair ingestion in children can prevent serious health issues.
September 2025 in “JAAD reviews.” Alopecia areata may slightly increase the risk of some pregnancy complications.
September 2025 in “Journal of the American Academy of Dermatology” Some JAK inhibitors are effective for significant hair regrowth in alopecia areata.
CRISPR gene editing reduces harmful molecules in cells from Emery–Dreifuss Muscular Dystrophy patients.
Female pattern hair loss and polycystic ovary syndrome are often linked.
May 2025 in “Journal of Cutaneous Medicine and Surgery” Online resources for hair loss need better quality and readability.
April 2025 in “Cermin Dunia Kedokteran” Graves' disease is a common cause of hyperthyroidism, mainly in women, treated with medication, iodine, or surgery, with varying outcomes.
February 2025 in “Journal of Clinical Investigation” RNase L hinders hair growth by altering immune signals.
January 2025 in “Clinical and Experimental Dermatology” Anti-inflammatory diets may help hair regrowth in alopecia areata.
December 2024 in “Journal of the International Society of Sports Nutrition” Creatine monohydrate is safe and effective for muscle recovery and performance, especially for those with low creatine levels.
December 2024 in “International Journal of Dermatology” JAK inhibitors may help treat both alopecia areata and vitiligo, but more research is needed.
November 2024 in “International Journal of Dermatology”
September 2024 in “Journal of the American Academy of Dermatology” The New York Times article boosted interest in using low dose oral minoxidil for hair loss.
September 2024 in “Journal of the American Academy of Dermatology” Dietary changes and supplements mostly did not improve alopecia areata.
September 2024 in “Journal of the American Academy of Dermatology” The supplements improved hair density and reduced hair loss.
August 2024 in “Journal of Small Animal Practice” A cat lost hair on its back a month after a road accident, despite no initial skin injuries.
July 2024 in “Skin Appendage Disorders” The supplement significantly improves hair density and appearance in people with hair loss.
April 2024 in “Journal of Investigative Dermatology” Using quantitative traits in genetics can improve understanding and management of skin health and conditions.
March 2024 in “GSC Advanced Research and Reviews” Different light affects cell functions and can help treat skin conditions.
Most dermatologists use and find oral minoxidil effective and tolerable for hair loss treatment.
February 2024 in “Archives of Dermatological Research” Most patients know about minoxidil for hair loss, but concerns about its use and effectiveness affect their decision to use it.
December 2023 in “Magna Scientia Advanced Research and Reviews” The document suggests using trazodone and clomiphene to treat sexual dysfunction caused by post-finasteride syndrome.
December 2023 in “Journal of Drugs in Dermatology” Media coverage increased public interest in oral minoxidil for hair loss but may also spread misinformation.
November 2023 in “Magna Scientia Advanced Research and Reviews” Trazodone might help reverse post finasteride syndrome.
October 2023 in “Psychiatry research. Case reports” A new HRAS gene variant may cause a range of symptoms including intellectual disability and psychiatric issues.